カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の頭蓋内アテローム性動脈硬化症治療市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Intracranial Atherosclerotic Disease Treatment Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO17981）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO17981
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：90
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の頭蓋内アテローム性動脈硬化症治療市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

頭蓋内アテローム性動脈硬化症治療市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の頭蓋内アテローム性動脈硬化症治療の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

頭蓋内アテローム性動脈硬化症治療市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ステント、PTAバルーン

用途別セグメントは次のように区分されます。
・病院、診療所、その他

世界の頭蓋内アテローム性動脈硬化症治療市場の主要な市場プレーヤーは以下のとおりです。
・Stryker、Balt、TERUMO、MicroPort、Acandis

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、頭蓋内アテローム性動脈硬化症治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な頭蓋内アテローム性動脈硬化症治療メーカーの企業概要、2019年～2022年までの頭蓋内アテローム性動脈硬化症治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な頭蓋内アテローム性動脈硬化症治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別頭蓋内アテローム性動脈硬化症治療の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの頭蓋内アテローム性動脈硬化症治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での頭蓋内アテローム性動脈硬化症治療市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および頭蓋内アテローム性動脈硬化症治療の産業チェーンを掲載しています。
・第13、14、15章では、頭蓋内アテローム性動脈硬化症治療の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 頭蓋内アテローム性動脈硬化症治療の概要
- 種類別分析（2017年vs2021年vs2028年）：ステント、PTAバルーン
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
- 世界の頭蓋内アテローム性動脈硬化症治療市場規模・予測
- 世界の頭蓋内アテローム性動脈硬化症治療生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Stryker、Balt、TERUMO、MicroPort、Acandis
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ステント、PTAバルーン
・用途別分析2017年-2028年：病院、診療所、その他
・頭蓋内アテローム性動脈硬化症治療の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・頭蓋内アテローム性動脈硬化症治療のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・頭蓋内アテローム性動脈硬化症治療のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・頭蓋内アテローム性動脈硬化症治療の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・頭蓋内アテローム性動脈硬化症治療の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Intracranial Atherosclerotic Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Intracranial Atherosclerotic Disease Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Intracranial Atherosclerotic Disease Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Stent segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Intracranial Atherosclerotic Disease Treatment include Stryker, Balt, TERUMO, MicroPort, and Acandis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Intracranial Atherosclerotic Disease Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Stent
PTA Balloon
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Intracranial Atherosclerotic Disease Treatment market are listed below:
Stryker
Balt
TERUMO
MicroPort
Acandis
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intracranial Atherosclerotic Disease Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intracranial Atherosclerotic Disease Treatment, with price, sales, revenue and global market share of Intracranial Atherosclerotic Disease Treatment from 2019 to 2022.
Chapter 3, the Intracranial Atherosclerotic Disease Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intracranial Atherosclerotic Disease Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Intracranial Atherosclerotic Disease Treatment market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Intracranial Atherosclerotic Disease Treatment.
Chapter 13, 14, and 15, to describe Intracranial Atherosclerotic Disease Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Intracranial Atherosclerotic Disease Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Intracranial Atherosclerotic Disease Treatment Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Stent
1.2.3 PTA Balloon
1.3 Market Analysis by Application
1.3.1 Overview: Global Intracranial Atherosclerotic Disease Treatment Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Intracranial Atherosclerotic Disease Treatment Market Size & Forecast
1.4.1 Global Intracranial Atherosclerotic Disease Treatment Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Intracranial Atherosclerotic Disease Treatment Sales in Volume (2017-2028)
1.4.3 Global Intracranial Atherosclerotic Disease Treatment Price (2017-2028)
1.5 Global Intracranial Atherosclerotic Disease Treatment Production Capacity Analysis
1.5.1 Global Intracranial Atherosclerotic Disease Treatment Total Production Capacity (2017-2028)
1.5.2 Global Intracranial Atherosclerotic Disease Treatment Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Intracranial Atherosclerotic Disease Treatment Market Drivers
1.6.2 Intracranial Atherosclerotic Disease Treatment Market Restraints
1.6.3 Intracranial Atherosclerotic Disease Treatment Trends Analysis
2 Manufacturers Profiles
2.1 Stryker
2.1.1 Stryker Details
2.1.2 Stryker Major Business
2.1.3 Stryker Intracranial Atherosclerotic Disease Treatment Product and Services
2.1.4 Stryker Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Balt
2.2.1 Balt Details
2.2.2 Balt Major Business
2.2.3 Balt Intracranial Atherosclerotic Disease Treatment Product and Services
2.2.4 Balt Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 TERUMO
2.3.1 TERUMO Details
2.3.2 TERUMO Major Business
2.3.3 TERUMO Intracranial Atherosclerotic Disease Treatment Product and Services
2.3.4 TERUMO Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 MicroPort
2.4.1 MicroPort Details
2.4.2 MicroPort Major Business
2.4.3 MicroPort Intracranial Atherosclerotic Disease Treatment Product and Services
2.4.4 MicroPort Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Acandis
2.5.1 Acandis Details
2.5.2 Acandis Major Business
2.5.3 Acandis Intracranial Atherosclerotic Disease Treatment Product and Services
2.5.4 Acandis Intracranial Atherosclerotic Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Intracranial Atherosclerotic Disease Treatment Breakdown Data by Manufacturer
3.1 Global Intracranial Atherosclerotic Disease Treatment Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Intracranial Atherosclerotic Disease Treatment
3.4 Market Concentration Rate
3.4.1 Top 3 Intracranial Atherosclerotic Disease Treatment Manufacturer Market Share in 2021
3.4.2 Top 6 Intracranial Atherosclerotic Disease Treatment Manufacturer Market Share in 2021
3.5 Global Intracranial Atherosclerotic Disease Treatment Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Intracranial Atherosclerotic Disease Treatment Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Intracranial Atherosclerotic Disease Treatment Market Size by Region
4.1.1 Global Intracranial Atherosclerotic Disease Treatment Sales in Volume by Region (2017-2028)
4.1.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2017-2028)
4.2 North America Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028)
4.3 Europe Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028)
4.4 Asia-Pacific Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028)
4.5 South America Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028)
4.6 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Intracranial Atherosclerotic Disease Treatment Sales in Volume by Type (2017-2028)
5.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Type (2017-2028)
5.3 Global Intracranial Atherosclerotic Disease Treatment Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Intracranial Atherosclerotic Disease Treatment Sales in Volume by Application (2017-2028)
6.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Application (2017-2028)
6.3 Global Intracranial Atherosclerotic Disease Treatment Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2028)
7.2 North America Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2028)
7.3 North America Intracranial Atherosclerotic Disease Treatment Market Size by Country
7.3.1 North America Intracranial Atherosclerotic Disease Treatment Sales in Volume by Country (2017-2028)
7.3.2 North America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2028)
8.2 Europe Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2028)
8.3 Europe Intracranial Atherosclerotic Disease Treatment Market Size by Country
8.3.1 Europe Intracranial Atherosclerotic Disease Treatment Sales in Volume by Country (2017-2028)
8.3.2 Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2028)
9.2 Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2028)
9.3 Asia-Pacific Intracranial Atherosclerotic Disease Treatment Market Size by Region
9.3.1 Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2028)
10.2 South America Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2028)
10.3 South America Intracranial Atherosclerotic Disease Treatment Market Size by Country
10.3.1 South America Intracranial Atherosclerotic Disease Treatment Sales in Volume by Country (2017-2028)
10.3.2 South America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2028)
11.2 Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2028)
11.3 Middle East & Africa Intracranial Atherosclerotic Disease Treatment Market Size by Country
11.3.1 Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Intracranial Atherosclerotic Disease Treatment and Key Manufacturers
12.2 Manufacturing Costs Percentage of Intracranial Atherosclerotic Disease Treatment
12.3 Intracranial Atherosclerotic Disease Treatment Production Process
12.4 Intracranial Atherosclerotic Disease Treatment Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Intracranial Atherosclerotic Disease Treatment Typical Distributors
13.3 Intracranial Atherosclerotic Disease Treatment Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Intracranial Atherosclerotic Disease Treatment Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Intracranial Atherosclerotic Disease Treatment Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Stryker Basic Information, Manufacturing Base and Competitors
Table 4. Stryker Major Business
Table 5. Stryker Intracranial Atherosclerotic Disease Treatment Product and Services
Table 6. Stryker Intracranial Atherosclerotic Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Balt Basic Information, Manufacturing Base and Competitors
Table 8. Balt Major Business
Table 9. Balt Intracranial Atherosclerotic Disease Treatment Product and Services
Table 10. Balt Intracranial Atherosclerotic Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. TERUMO Basic Information, Manufacturing Base and Competitors
Table 12. TERUMO Major Business
Table 13. TERUMO Intracranial Atherosclerotic Disease Treatment Product and Services
Table 14. TERUMO Intracranial Atherosclerotic Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. MicroPort Basic Information, Manufacturing Base and Competitors
Table 16. MicroPort Major Business
Table 17. MicroPort Intracranial Atherosclerotic Disease Treatment Product and Services
Table 18. MicroPort Intracranial Atherosclerotic Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Acandis Basic Information, Manufacturing Base and Competitors
Table 20. Acandis Major Business
Table 21. Acandis Intracranial Atherosclerotic Disease Treatment Product and Services
Table 22. Acandis Intracranial Atherosclerotic Disease Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Intracranial Atherosclerotic Disease Treatment Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 24. Global Intracranial Atherosclerotic Disease Treatment Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Intracranial Atherosclerotic Disease Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Intracranial Atherosclerotic Disease Treatment Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Intracranial Atherosclerotic Disease Treatment Production Site of Key Manufacturer
Table 28. Intracranial Atherosclerotic Disease Treatment New Entrant and Capacity Expansion Plans
Table 29. Intracranial Atherosclerotic Disease Treatment Mergers & Acquisitions in the Past Five Years
Table 30. Global Intracranial Atherosclerotic Disease Treatment Sales by Region (2017-2022) & (K Units)
Table 31. Global Intracranial Atherosclerotic Disease Treatment Sales by Region (2023-2028) & (K Units)
Table 32. Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Intracranial Atherosclerotic Disease Treatment Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 35. Global Intracranial Atherosclerotic Disease Treatment Sales by Type (2023-2028) & (K Units)
Table 36. Global Intracranial Atherosclerotic Disease Treatment Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Intracranial Atherosclerotic Disease Treatment Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Intracranial Atherosclerotic Disease Treatment Price by Type (2017-2022) & (US$/Unit)
Table 39. Global Intracranial Atherosclerotic Disease Treatment Price by Type (2023-2028) & (US$/Unit)
Table 40. Global Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 41. Global Intracranial Atherosclerotic Disease Treatment Sales by Application (2023-2028) & (K Units)
Table 42. Global Intracranial Atherosclerotic Disease Treatment Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Intracranial Atherosclerotic Disease Treatment Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Intracranial Atherosclerotic Disease Treatment Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Intracranial Atherosclerotic Disease Treatment Price by Application (2023-2028) & (US$/Unit)
Table 46. North America Intracranial Atherosclerotic Disease Treatment Sales by Country (2017-2022) & (K Units)
Table 47. North America Intracranial Atherosclerotic Disease Treatment Sales by Country (2023-2028) & (K Units)
Table 48. North America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 51. North America Intracranial Atherosclerotic Disease Treatment Sales by Type (2023-2028) & (K Units)
Table 52. North America Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 53. North America Intracranial Atherosclerotic Disease Treatment Sales by Application (2023-2028) & (K Units)
Table 54. Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2017-2022) & (K Units)
Table 55. Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2023-2028) & (K Units)
Table 56. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 59. Europe Intracranial Atherosclerotic Disease Treatment Sales by Type (2023-2028) & (K Units)
Table 60. Europe Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 61. Europe Intracranial Atherosclerotic Disease Treatment Sales by Application (2023-2028) & (K Units)
Table 62. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales by Region (2017-2022) & (K Units)
Table 63. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales by Region (2023-2028) & (K Units)
Table 64. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 67. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales by Type (2023-2028) & (K Units)
Table 68. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 69. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales by Application (2023-2028) & (K Units)
Table 70. South America Intracranial Atherosclerotic Disease Treatment Sales by Country (2017-2022) & (K Units)
Table 71. South America Intracranial Atherosclerotic Disease Treatment Sales by Country (2023-2028) & (K Units)
Table 72. South America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 75. South America Intracranial Atherosclerotic Disease Treatment Sales by Type (2023-2028) & (K Units)
Table 76. South America Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 77. South America Intracranial Atherosclerotic Disease Treatment Sales by Application (2023-2028) & (K Units)
Table 78. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales by Region (2017-2022) & (K Units)
Table 79. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales by Region (2023-2028) & (K Units)
Table 80. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales by Type (2017-2022) & (K Units)
Table 83. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales by Type (2023-2028) & (K Units)
Table 84. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales by Application (2017-2022) & (K Units)
Table 85. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales by Application (2023-2028) & (K Units)
Table 86. Intracranial Atherosclerotic Disease Treatment Raw Material
Table 87. Key Manufacturers of Intracranial Atherosclerotic Disease Treatment Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Intracranial Atherosclerotic Disease Treatment Typical Distributors
Table 91. Intracranial Atherosclerotic Disease Treatment Typical Customers
List of Figures
Figure 1. Intracranial Atherosclerotic Disease Treatment Picture
Figure 2. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type in 2021
Figure 3. Stent
Figure 4. PTA Balloon
Figure 5. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Global Intracranial Atherosclerotic Disease Treatment Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Intracranial Atherosclerotic Disease Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Intracranial Atherosclerotic Disease Treatment Sales (2017-2028) & (K Units)
Figure 12. Global Intracranial Atherosclerotic Disease Treatment Price (2017-2028) & (US$/Unit)
Figure 13. Global Intracranial Atherosclerotic Disease Treatment Production Capacity (2017-2028) & (K Units)
Figure 14. Global Intracranial Atherosclerotic Disease Treatment Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Intracranial Atherosclerotic Disease Treatment Market Drivers
Figure 16. Intracranial Atherosclerotic Disease Treatment Market Restraints
Figure 17. Intracranial Atherosclerotic Disease Treatment Market Trends
Figure 18. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Manufacturer in 2021
Figure 19. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Manufacturer in 2021
Figure 20. Intracranial Atherosclerotic Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Intracranial Atherosclerotic Disease Treatment Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Intracranial Atherosclerotic Disease Treatment Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2017-2028)
Figure 24. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2017-2028)
Figure 25. North America Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (USD Million)
Figure 26. Europe Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (USD Million)
Figure 28. South America Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue (2017-2028) & (USD Million)
Figure 30. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2017-2028)
Figure 31. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2017-2028)
Figure 32. Global Intracranial Atherosclerotic Disease Treatment Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2017-2028)
Figure 34. Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2017-2028)
Figure 35. Global Intracranial Atherosclerotic Disease Treatment Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2017-2028)
Figure 37. North America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2017-2028)
Figure 38. North America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country (2017-2028)
Figure 39. North America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country (2017-2028)
Figure 40. United States Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2017-2028)
Figure 44. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2017-2028)
Figure 45. Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country (2017-2028)
Figure 46. Europe Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country (2017-2028)
Figure 47. Germany Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2017-2028)
Figure 56. China Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2017-2028)
Figure 63. South America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2017-2028)
Figure 64. South America Intracranial Atherosclerotic Disease Treatment Sales Market Share by Country (2017-2028)
Figure 65. South America Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Intracranial Atherosclerotic Disease Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Intracranial Atherosclerotic Disease Treatment in 2021
Figure 77. Manufacturing Process Analysis of Intracranial Atherosclerotic Disease Treatment
Figure 78. Intracranial Atherosclerotic Disease Treatment Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の胃食道逆流症（GERD）治療装置市場2022年：市場規模予測（～2028年）
  • 世界のバセドウ病治療市場2022年：市場規模予測（～2028年）
  • 呼吸器疾患治療のグローバル市場展望 2023年-2029年：吸入＆点鼻薬、経口薬、その他
  • 頭蓋内シャント機器のグローバル市場展望 2023年-2029年：大人、子供
  • 末梢動脈疾患治療の世界市場 2022年-2026年
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO17981 )"世界の頭蓋内アテローム性動脈硬化症治療市場2022年：市場規模予測（～2028年）" (英文：Global Intracranial Atherosclerotic Disease Treatment Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。